.png){kind=logo}
Record order book, rising profits and lower debt strengthen KPIL’s growth visibility.
CUB & PVR INOX show improving asset quality, and a Rs. 300 crore buyback provides fresh investor triggers.
KIMS & CUMI’s expansion and industrial growth are promising, but profitability and valuation require close monitoring.
Indian equities have several less-talked-about names with strong recent numbers. Five stocks stand out from the latest results: Kalpataru Projects International, KIMS, City Union Bank, PVR INOX and Carborundum Universal. Each has a clear reason for market interest. KPIL has a record order book, CUB has a sharp asset-quality recovery, PVR INOX has a new capital-return trigger, CUMI has broad business growth, while KIMS has built a much larger hospital network.
Kalpataru Projects International has delivered the strongest mix of profit growth and order visibility among the five names. Q1 FY27 revenue rose 4% year on year to Rs. 6,408 crore, while Profit After Tax rose 46% to Rs. 312 crore. EBITDA rose 7% to Rs. 562 crore, with the EBITDA margin at 8.8%. The order book reached a record Rs. 66,607 crore as of June 30, 2026. FY27 order inflow stood at Rs. 7,668 crore, while another Rs. 7,300 crore of orders had favourable placement or L1 status.
Net debt fell 67% year on year to Rs. 917 crore, and working capital days improved to 80 from 91. KPIL also won about Rs. 3,526 crore of fresh domestic orders in August, which took FY27 order intake above Rs. 11,000 crore. The stock trades near Rs. 1,410, with a 52-week range of about Rs. 1,007 to Rs. 1,480. The main test now lies in project execution, cash flow, and margin control.
KIMS Hospitals presents a more mixed picture. Revenue from operations reached Rs. 1,180 crore in Q1 FY27, up 35.3% year on year. EBITDA before Ind AS rose 14.6% to Rs. 222 crore. Yet PAT fell 47.2% to about Rs. 41.5 crore. Total bed capacity rose to 7,459 as of June 30, 2026, from 5,499 a year earlier.
KIMS also raised Rs. 1,500 crore through a QIP, with a large part directed toward debt reduction. The company plans a 500-bed multispecialty hospital in Amaravati. The key issue now is whether newer facilities can reach better occupancy and support stronger profit margins. The stock trades near Rs. 750–760, so earnings recovery remains central to the story.
City Union Bank has quietly improved several core bank numbers. Q1 FY27 net profit rose 25% year on year to Rs. 382.57 crore. Net interest income stood at Rs. 820.10 crore, while deposits reached Rs. 79,342.3 crore and advances stood at Rs. 67,645.4 crore. Gross bad loans fell to Rs. 1,170 crore from Rs. 1,617 crore a year earlier.
The gross NPA ratio dropped to 1.73% from 2.99%, while net NPA stood at 0.61% against 1.20%. Net interest margin was 3.78%, and capital adequacy stood at 21.73%. The stock trades near Rs. 230, close to its 52-week high of about Rs. 245. Loan growth, deposit quality and margin protection now matter most.
Also Read - What are Tech Stocks? Understanding IT Sector Companies and Their Stocks
PVR INOX has moved from a recovery story toward a stronger cash-flow story. Q1 FY27 revenue rose 11.9% year on year to Rs. 1,622.2 crore. EBITDA reached Rs. 528 crore, up about 31%, while PAT stood at Rs. 56.5 crore against a loss of Rs. 54.5 crore a year earlier. Admissions rose 8% to 36.6 million, average ticket price rose 8% to Rs. 273, and food and beverage spend per head rose 9% to Rs. 161. The company also turned net cash positive at Rs. 80.7 crore as of June 30, 2026.
On August 31, the board approved its first share buyback of up to 20.69 lakh shares at Rs. 1,450 each, with a total value of up to Rs. 300 crore. September 4, 2026 is the record date. The stock trades near Rs. 1,210–1,220. Future results still depend on movie supply, occupancy, and customer spend.
Carborundum Universal has produced solid growth across its three main segments. Q1 FY27 consolidated sales rose 16.9% year on year to Rs. 1,411 crore, while PAT rose 23.4% to Rs. 76.4 crore. Abrasives sales rose 20.1%, Ceramics rose 16.5%, and Electrominerals rose 16.8%. The company also raised its FY27 Ceramics growth guidance to 23–25% from about 15–15.5%.
CUMI has a low debt-to-equity ratio of about 0.05, which gives its balance sheet room for capital expenditure. The stock trades near 99 times past earnings in one current data set. Raw material costs have also hurt Abrasives' margins. The stock trades near Rs. 1,073–1,082. The business looks strong, but the valuation leaves less room for weak results.
Why this Matters
These five stocks matter as each has a clear company-specific trigger that can shape investor interest. Strong orders, better asset quality, hospital expansion, higher cinema profits and industrial growth offer different paths for future performance. The latest numbers also show where risks remain, which makes these lesser-known names worth closer market attention.
Also Read - 8 Stocks Behind India EV Boom
The five names now offer five distinct market stories. KPIL has order visibility and sharp profit growth. CUB has clear asset-quality improvement. PVR INOX has stronger cash generation and a Rs. 300 crore buyback. CUMI has broad industrial demand and higher Ceramics guidance.
KIMS has rapid revenue growth and a large hospital expansion plan, but its profit trend needs closer attention. The common thread is a specific business change behind each story, rather than a broad market theme. The next few quarters can show whether these signals have real durability.
1. Which five under-the-radar Indian stocks are highlighted?
Kalpataru Projects International, KIMS Hospitals, City Union Bank, PVR INOX and Carborundum Universal.
2. Why is KPIL attracting investor attention?
Its record Rs. 66,607 crore order book, strong Q1 FY27 profit growth and declining net debt offer significant order and earnings visibility.
3. What is the key trigger for PVR INOX?
The company approved its first share buyback of up to Rs. 300 crore at Rs. 1,450 per share, with September 4, 2026 as the record date.
4. Why is City Union Bank's performance notable?
Its gross NPA ratio declined to 1.73% from 2.99%, while Q1 FY27 net profit rose 25% year on year.
5. What are the main risks for these stocks?
Execution, margin pressure, occupancy, loan and deposit growth, hospital ramp-up and high valuations could influence their future performance.
